Pharmesis International Ltd. reported unaudited consolidated earnings results for the first quarter ended March 31, 2015. For the quarter, the company reported revenue of RMB 14.038 million compared to RMB 13.434 million a year ago. Loss from operations was RMB 0.737 million compared to RMB 1.777 million a year ago.

Profit before tax was RMB 0.151 million compared to loss of RMB 1.126 million a year ago. Profit attributable to equity holders of the company of RMB 0.296 million compared to loss of RMB 0.459 million a year ago. Net cash flows from operating activities were of RMB 1.469 million compared to RMB 0.872 million a year ago.

Acquisition of property, plant and equipment were of RMB 4,000 compared to RMB 83,000 a year ago.